CVE-2021-1384

Public Exploit
Cisco IOx for IOS XE Software Command Injection Vulnerability

Description

A vulnerability in Cisco IOx application hosting environment of Cisco IOS XE Software could allow an authenticated, remote attacker to inject commands into the underlying operating system as the root user. This vulnerability is due to incomplete validation of fields in the application packages loaded onto IOx. An attacker could exploit this vulnerability by creating a crafted application .tar file and loading it onto the device. A successful exploit could allow the attacker to perform command injection into the underlying operating system as the root user.

Categories

6.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 18.76% Top 10%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-1384?
CVE-2021-1384 has been scored as a medium severity vulnerability.
How to fix CVE-2021-1384?
To fix CVE-2021-1384, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-1384 being actively exploited in the wild?
It is possible that CVE-2021-1384 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~19% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-1384?
CVE-2021-1384 affects Cisco Cisco IOS XE Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.